Hebei Changshan Biochemical Hits Day Low at CNY 25.41 Amid Price Pressure

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 4.67% and reaching an intraday low of CNY 25.41. This performance stands in contrast to the China Shanghai Composite, which fell by only 1.16% on the same day. Over the past week, Hebei Changshan has seen a more pronounced decline of 10.54%, while its monthly performance shows a gain of 11.97%. However, the longer-term outlook remains challenging, with a staggering 39.65% drop over the past year and a year-to-date decline of 58.87%. In stark contrast, the China Shanghai Composite has gained 5.99% over the past year. The company's financial metrics reveal a weak long-term fundamental strength, highlighted by a low average Return on Capital Employed (ROCE) of 3.59%. Additionally, the company has reported negative results for the last four consecutive quarters, with a net profit of CNY -322.94 million, reflecting a decline of 62.45%. Despite being net-debt free, the stock's performance has raised concerns, particularly given its significant underperformance relative to the broader market.